Sabme Pharmaceuticals Private Limited

Sabme Pharmaceuticals Private Limited - engineering in Jamshedpur, Jharkhand, India. FY 2026 financials & compliance.
CIN U74999JH2018PTC012244 Incorporated 06 December 2018 ROC Ranchi HQ Jamshedpur, Jharkhand, India
Active Private Limited Company engineering MSME · Micro
Revenue · FY 2025
₹2.53 Cr
▲ 6% YoY
Net profit · FY 2025
₹8.32 Lakh
Net margin 3.3%
EBITDA · FY 2025
₹28 Lakh
EBITDA margin 11.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹96.58 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings

About Sabme Pharmaceuticals Private Limited

Data last updated:

Sabme Pharmaceuticals Private Limited is a private limited company based in Jamshedpur, Jharkhand, India. It operates in the engineering design and consultancy segment of the engineering sector. It was incorporated on 06 December 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U74999JH2018PTC012244. Its GSTIN is 20ABBCS2343B1Z7 (Jharkhand).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Resham Kaur and Rishab Agarwal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – 205 Block B – 1 2nd Floor Sai Niwas Sai Complex Baliguma, Jamshedpur, Jharkhand, India – 831018.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.53 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹8.32 Lakh (net margin 3.3%) and EBITDA of ₹28 Lakh (EBITDA margin 11.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 28% over five years.

As per MCA filings, the company has open charges of ₹96.58 Lakh on record.

Sabme Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JH-06-0022488).

Company details

CIN U74999JH2018PTC012244
Registration Number 012244
Incorporation Date 06 December 2018
ROC Ranchi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-JH-06-0022488

Recognitions & Rankings of Sabme Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-JH-06-0022488

Contact details

Sabme Pharmaceuticals Private Limited's registered office is in Jamshedpur, Jharkhand. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Flat No – 205 Block B – 1 2nd Floor Sai Niwas Sai Complex Baliguma, Jamshedpur, Jharkhand, India – 831018
  • Industry
    Engineering, Engineering Design & Consultancy

To see the full contact details of Sabme Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Sabme Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Sabme Pharmaceuticals Private Limited

FY 2025 filings available

Sabme Pharmaceuticals Private Limited reported revenue of ₹2.53 Cr (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹2.53 Cr ▲ 6%
Net profit · FY 2025
₹8.32 Lakh margin 3.3%
EBITDA · FY 2025
₹28 Lakh margin 11.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 16%
5 years · compounded
▲ 28%
EBITDA CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 30%
5 years · compounded
▲ 52%

Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 6% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹28 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹8.32 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin11.1%
Net Profit Margin3.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sabme Pharmaceuticals Private Limited, buy the company report.

Board of directors of Sabme Pharmaceuticals Private Limited

Sabme Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Resham KaurDirector06 Dec 20187 Years 11 MonthsCurrent
Rishab AgarwalDirector06 Dec 20187 Years 11 MonthsCurrent

Peer comparison

Sabme Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Xiolife Pharmaceuticals and Healthcare Private Limited₹2.53 Cr (FY 2025)82.0%Guwahati, Assam, India
Biomics Pharmaceuticals Private Limited₹2.53 Cr (FY 2025)3.0%Karur, Tamil Nadu, India
Sabme Pharmaceuticals Private Limitedthis company₹2.53 Cr (FY 2025)₹8.32 Lakh3.3%6.0%Jamshedpur, Jharkhand, India
Novorem Pharmaceuticals Private Limited₹2.53 Cr (FY 2025)16.0%New Delhi, Delhi, India

To see the full peer comparison of Sabme Pharmaceuticals Private Limited, buy the company report.

Auditor

Sabme Pharmaceuticals Private Limited is audited by SUMIT M AGARWAL & CO for the financial year 2022.

Auditor firmFinancial yearFirm registration number
SUMIT M AGARWAL & COFY 2022427015

Shareholding

The shareholding of Sabme Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sabme Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹96.58 Lakh
Satisfied charges
None
Breakdown by lending institutions
Bank of India₹0.62 Cr
Hdfc Bank Limited₹0.35 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
26 Mar 2025101091451Bank of India₹20 LakhOpen
12 Mar 2025101065122Bank of India₹9.5 LakhOpen
12 Mar 2025101065132Bank of India₹32 LakhOpen
21 Jun 2022100873914Hdfc Bank Limited₹21.08 LakhOpen
03 Mar 2021100444312Hdfc Bank Limited₹14 LakhOpen

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sabme Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Sabme Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
20ABBCS2343B1Z7JharkhandActive25 Feb 2019

To see the full GST registrations and return filing status of Sabme Pharmaceuticals Private Limited, buy the company report.

Recent activity

Sabme Pharmaceuticals Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Indrajit Singh ceased to be Director on 26 Feb 2024.

AGM
Sabme Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sabme Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ranchi.
Charges
A charge with Bank Of India amounted to Rs. 20.00 Lakh with Charge ID 101091451 was registered on 26 Mar 2025.
Charges
A charge with Bank Of India amounted to Rs. 9.50 Lakh with Charge ID 101065122 was registered on 12 Mar 2025.
Charges
A charge with Bank Of India amounted to Rs. 32.00 Lakh with Charge ID 101065132 was registered on 12 Mar 2025.
Ceased
Indrajit Singh ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 21.08 Lakh with Charge ID 100873914 was registered on 21 Jun 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 14.00 Lakh with Charge ID 100444312 was registered on 03 Mar 2021.
Appointed
Resham Kaur was appointed as Director.
Appointed
Rishab Agarwal was appointed as Director.
Incorporation
06 Dec 2018
Sabme Pharmaceuticals Private Limited was registered on 06 Dec 2018 with Roc Ranchi & aged 7 years 11 months as per MCA records.

Frequently asked questions

Sabme Pharmaceuticals is an active private limited company based in Jamshedpur, Jharkhand, India. The company works in engineering design and consultancy, within the engineering industry. It was incorporated on 06 December 2018 (8+ years old) and is registered under CIN U74999JH2018PTC012244.

Sabme Pharmaceuticals has 2 current directors:

The latest financial statements of Sabme Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Sabme Pharmaceuticals is 20ABBCS2343B1Z7, registered in Jharkhand.

The CIN (Corporate Identification Number) of Sabme Pharmaceuticals is U74999JH2018PTC012244. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sabme Pharmaceuticals was incorporated on 06 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Ranchi.

The peers of Sabme Pharmaceuticals by revenue are Xiolife Pharmaceuticals and Healthcare Private Limited, Biomics Pharmaceuticals Private Limited, Novorem Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Indrajit Singh ceased to be Director on 26 Feb 2024. Resham Kaur was appointed as Director on 06 Dec 2018. Rishab Agarwal was appointed as Director on 06 Dec 2018.

Yes, Sabme Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-JH-06-0022488).

The registered office of Sabme Pharmaceuticals is at Flat No – 205 Block B – 1 2nd Floor Sai Niwas Sai Complex Baliguma, Jamshedpur, Jharkhand, India – 831018.

Sabme Pharmaceuticals operates in the engineering industry, in the engineering design and consultancy segment.